General Information of the Compound
| Compound ID |
CP0951739
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5R*)-N5-(2-(4-Methylphenyl)ethyl)-(6R*)-N6-(4-pyrrolidino-butyl)-(4S*,7R*)-[4,7-ethenylene-spiro[2.4]heptane]-5,6-dicarboxamide, formate salt
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H41N3O4
|
||||||||||||||||||
| Molecular Weight |
495.664
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc(CCNC(=O)[C@H]2[C@H](C(=O)NCCCCN3CCCC3)[C@H]3C=C[C@@H]2C32CC2)cc1.O=CO
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H39N3O2.CH2O2/c1-20-6-8-21(9-7-20)12-16-30-27(33)25-23-11-10-22(28(23)13-14-28)24(25)26(32)29-15-2-3-17-31-18-4-5-19-31;2-1-3/h6-11,22-25H,2-5,12-19H2,1H3,(H,29,32)(H,30,33);1H,(H,2,3)/t22-,23+,24-,25-;/m1./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
CHFQNAZQSYMHPL-AVHAYRAPSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00605, FML2_HUMAN
Protein ID: PT02590, N-formyl peptide receptor 2